{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T10:14:37Z","timestamp":1742379277174},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.tripleo.2008.03.005","type":"journal-article","created":{"date-parts":[[2008,6,28]],"date-time":"2008-06-28T09:28:20Z","timestamp":1214645300000},"page":"e18-e21","source":"Crossref","is-referenced-by-count":10,"title":["Oral osteonecrosis associated with the use of ibandronate: report of a case and clinical implications"],"prefix":"10.1016","volume":"106","author":[{"given":"Cesar A.","family":"Migliorati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basil N.","family":"Armonis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ourania","family":"Nicolatou-Galitis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tripleo.2008.03.005_bib1","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1200\/JCO.2003.08.017","article-title":"American Society of Clinical Oncology 2003 Update on the Role of Bisphosphonates and Bone Health Issues in Women With Breast Cancer","volume":"21","author":"Hillner","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.tripleo.2008.03.005_bib2","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s00520-005-0913-5","article-title":"Bisphosphonates for malignancy-related bone disease: current status, future developments","volume":"14","author":"Body","year":"2006","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.tripleo.2008.03.005_bib3","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.2165\/00002018-200629120-00005","article-title":"Tolerability of different dosing regimens of bisphosphonates for the treatment of osteoporosis and malignant disease","volume":"29","author":"Bobba","year":"2006","journal-title":"Drug Saf"},{"issue":"Suppl.5","key":"10.1016\/j.tripleo.2008.03.005_bib4","doi-asserted-by":"crossref","first-page":"S136","DOI":"10.1016\/S1359-6349(03)90480-0","article-title":"Alleviation of bone pain with oral and intravenous ibandronate in women with metastatic breast cancer","volume":"1","author":"Tripathy","year":"2003","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.tripleo.2008.03.005_bib5","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1093\/annonc\/mdg367","article-title":"Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases","volume":"14","author":"Body","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/j.tripleo.2008.03.005_bib9","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S1470-2045(06)70726-4","article-title":"Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment","volume":"7","author":"Migliorati","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.tripleo.2008.03.005_bib10","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.tripleo.2008.03.005_bib11","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","article-title":"Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases","volume":"62","author":"Ruggiero","year":"2004","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.tripleo.2008.03.005_bib12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/cncr.21130","article-title":"Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive care in cancer","volume":"104","author":"Migliorati","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.tripleo.2008.03.005_bib13","doi-asserted-by":"crossref","first-page":"753","DOI":"10.7326\/0003-4819-144-10-200605160-00009","article-title":"Systematic review: bisphosphonates and osteonecrosis of the jaws","volume":"144","author":"Woo","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.tripleo.2008.03.005_bib14","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1345\/aph.1E357","article-title":"Discovery, clinical development, and therapeutic uses of bisphosphonates","volume":"39","author":"Licata","year":"2005","journal-title":"Ann Pharmacother"},{"issue":"suppl","key":"10.1016\/j.tripleo.2008.03.005_bib15","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/BF03026321","article-title":"The effects of suppressed bone remodeling by bisphosphonates on microdamage accumulation and degree of mineralization in the cortical bone of dog rib","volume":"23","author":"Mashiba","year":"2005","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.tripleo.2008.03.005_bib16","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1210\/jc.2004-0952","article-title":"Severely suppressed bone turnover: a potential complication of alendronate therapy","volume":"90","author":"Odvina","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.tripleo.2008.03.005_bib17","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","article-title":"Bisphosphonate-induced exposed bone (osteonecrosis.osteopetrosis) of the jaws: risk factors, recognition, prevention and treatment","volume":"63","author":"Marx","year":"2005","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.tripleo.2008.03.005_bib18","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.14219\/jada.archive.2005.0108","article-title":"Managing the care of patients with bisphosphonate-associated osteonecrosis","volume":"136","author":"Migliorati","year":"2005","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/j.tripleo.2008.03.005_bib19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/bdj.2007.636","article-title":"Oral bisphosphonate associated osteonecrosis of the jaws: three case reports","volume":"203","author":"Malden","year":"2007","journal-title":"Br Dent J"},{"issue":"18s","key":"10.1016\/j.tripleo.2008.03.005_bib20","article-title":"Bisphosphonate use and osteonecrosis of the jaw: pharmacovigilance and reporting of this serious adverse event from the Research on Adverse Drug Events and Reports (RADAR) project","volume":"25","author":"Edwards","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.tripleo.2008.03.005_bib21","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.ejca.2006.12.006","article-title":"International society of geriatric oncology (SIOG) clinical practice recommendations for the use of bisphosphonates in the elderly","volume":"43","author":"Body","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.tripleo.2008.03.005_bib22","doi-asserted-by":"crossref","first-page":"755","DOI":"10.2165\/00002018-200730090-00003","article-title":"Safety considerations with bisphosphonates for the treatment of osteoporosis","volume":"30","author":"Strampel","year":"2007","journal-title":"Drug Saf"},{"key":"10.1016\/j.tripleo.2008.03.005_bib23","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1177\/0091270007301801","article-title":"Renal safety and pharmacokinectics of ibandronate in multiple myeloma patients with or without impaired renal function","volume":"47","author":"Bergner","year":"2007","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.tripleo.2008.03.005_bib24","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.2165\/00002018-200629120-00005","article-title":"Tolerability of different dosing of bisphosphonates for the treatment of osteoporosis and malignant bone disease","volume":"29","author":"Bobba","year":"2006","journal-title":"Drug Saf"},{"key":"10.1016\/j.tripleo.2008.03.005_bib25","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.clinthera.2005.08.006","article-title":"Cost-effectiveness of oral ibandronate versus IV zoledronic acid or IV pamidronate for bone metastases in patients receiving oral hormonal therapy for breast cancer in the United Kingdom","volume":"27","author":"De Cock","year":"2005","journal-title":"Clin Ther"},{"key":"10.1016\/j.tripleo.2008.03.005_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2007.11.012","article-title":"Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies","author":"Boonyapakorn","year":"2008","journal-title":"Oral Oncol"}],"container-title":["Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079210408002230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079210408002230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,12]],"date-time":"2019-05-12T11:10:43Z","timestamp":1557659443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079210408002230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S1079210408002230"],"URL":"https:\/\/doi.org\/10.1016\/j.tripleo.2008.03.005","relation":{},"ISSN":["1079-2104"],"issn-type":[{"value":"1079-2104","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}